EZH2 and melanoma: A significant increase in melanoma apoptosis, compared to treatment with single agents, was obtained even by association of EZH2 inhibitor GSK126 with the GSK-3β inhibitor AR-014418 (Fig. 7d), in agreement with the role of GSK-3β in NFATc2 regulation [39].